Envoy Medical - Class A (COCH) closed at $0.65 on October 19, 2026, down 2.1% from the previous close, on volume of 98,213 shares (30-day average 62,486).
Data as of October 19, 2026.
Envoy Medical Shareholders Approve Reverse Stock Split Plan
TipRanks (Fri, 16-Oct 5:02 PM ET)
Newsfile (Mon, 12-Oct 8:30 AM ET)
Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio
Newsfile (Tue, 22-Sep 8:30 AM ET)
Newsfile (Wed, 2-Sep 8:30 AM ET)
Newsfile (Mon, 10-Aug 8:01 AM ET)
Envoy Medical Surpasses Three-Month Visit Milestone for All 56 Patients in Pivotal Clinical Trial
Newsfile (Tue, 21-Jul 9:17 AM ET)
COCH Shares Rally as 12-Month Study Shows Acclaim Implant Achieves 38-Point Gain in Word Recognition
Market Chameleon (Tue, 14-Jul 6:29 AM ET)
Market Chameleon (Tue, 30-Jun 7:44 AM ET)
Market Chameleon (Tue, 7-Oct 5:53 AM ET)
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
Envoy Medical - Class A trades on the NASDAQ stock market under the symbol COCH.
As of October 19, 2026, COCH stock price declined to $0.65 with 98,213 million shares trading.
COCH has a beta of 1.13, meaning it tends to be more sensitive to market movements. COCH has a correlation of 0.03 to the broad based SPY ETF.
COCH has a market cap of $50.49 million. This is considered a Micro Cap stock.
Last quarter Envoy Medical - Class A reported $51,000 in Revenue and -$.07 earnings per share. This fell short of revenue expectation by $-25,000 and exceeded earnings estimates by $.01.
In the last 3 years, COCH traded as high as $11.46 and as low as $.36.
The top ETF exchange traded funds that COCH belongs to (by Net Assets): VXF, VTI.
COCH has underperformed the market in the last year with a price return of -23.1% while the SPY ETF gained +17.2%. COCH has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -14.0% and -3.5%, respectively, while the SPY returned +2.4% and -0.4%, respectively.
COCH support price is $.65 and resistance is $.69 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that COCH shares will trade within this expected range on the day.
